Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rupa Narayan, M.D.

Concepts (73)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Leukemia, Myeloid, Acute7202334741.170 Why?
Cytokine-Induced Killer Cells1201960.710 Why?
Myeloproliferative Disorders320226090.700 Why?
Hematopoietic Stem Cell Transplantation3202353810.520 Why?
HLA Antigens1201913810.460 Why?
Myelodysplastic Syndromes3202313560.460 Why?
Antigen Presentation1201912850.460 Why?
Immunoconjugates120198700.430 Why?
Antigens, Neoplasm1201919640.400 Why?
Tissue Donors1201922310.350 Why?
Nuclear Proteins2202358630.320 Why?
Hematologic Neoplasms1201917990.300 Why?
Antineoplastic Combined Chemotherapy Protocols22019113950.290 Why?
Recurrence4202382910.220 Why?
Leukemia, Myelomonocytic, Chronic12023980.220 Why?
Multiple Myeloma1202051220.210 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma2202215070.210 Why?
Mitoxantrone120191480.180 Why?
Philadelphia Chromosome120201130.180 Why?
Maximum Tolerated Dose220198870.180 Why?
Azacitidine220233260.170 Why?
Disease-Free Survival2201968920.170 Why?
Etoposide120196370.160 Why?
Cytarabine120196840.160 Why?
Frameshift Mutation120194000.150 Why?
Eosinophilia120205310.140 Why?
Antifungal Agents120207240.130 Why?
BH3 Interacting Domain Death Agonist Protein12015930.130 Why?
Retreatment120156030.120 Why?
Silymarin12013410.120 Why?
Phosphatidylcholines120134230.100 Why?
Drug Administration Schedule1201949350.100 Why?
Thalidomide120158760.090 Why?
Graft vs Host Disease1202229150.090 Why?
Genotype12023129630.080 Why?
Adult620232132830.080 Why?
Chronic Disease1202391100.080 Why?
Aged520201626790.070 Why?
Antibodies, Monoclonal1202392730.070 Why?
Middle Aged620202131150.070 Why?
Proteomics1201935660.070 Why?
Humans1520237369400.070 Why?
Bone Marrow1201529240.070 Why?
Antioxidants1201316690.060 Why?
Aged, 80 and over32020577380.060 Why?
Drug Resistance, Neoplasm1201951520.060 Why?
Survival Rate12019127820.060 Why?
In Situ Hybridization, Fluorescence2202226620.060 Why?
Male720223490250.060 Why?
Retrospective Studies22023762000.060 Why?
Oncogene Proteins, Fusion2202215940.050 Why?
Neoplasms22021214100.050 Why?
Female520203785100.050 Why?
Nuclear Pore Complex Proteins120221700.050 Why?
Carcinoma, Hepatocellular1201321860.050 Why?
Antimetabolites, Antineoplastic120236410.040 Why?
Age Factors12015183590.040 Why?
Liver Neoplasms1201342200.040 Why?
Genetic Predisposition to Disease12019174190.040 Why?
Young Adult22020562390.040 Why?
Antibodies1202324440.030 Why?
Treatment Outcome22023625010.030 Why?
Cardiovascular Diseases12019149680.030 Why?
Pyrazoles1202019580.020 Why?
Pyrimidines1202029060.020 Why?
Immunotherapy1202243500.020 Why?
Incidence12020208830.010 Why?
Dose-Response Relationship, Drug12013109580.010 Why?
Prognosis12019289670.010 Why?
Risk Assessment12019232980.010 Why?
Disease Progression12013132460.010 Why?
Mutation12019298440.010 Why?
Risk Factors12019717840.010 Why?
Narayan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (73)
Explore
_
Co-Authors (31)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.